Frazier Healthcare Partners portfolio
51 tracked investments, 7 on the map, $3B raised across the mapped portfolio.
- Rocket PharmaceuticalsPost-IPO Equity
- Arcutis BiotherapeuticsSeries C
- Scholar Rock
- Krystal BiotechPost-IPO Equity
- REGENXBIOPost-IPO Equity
- Tarsus Pharmaceuticals
- AnaptysBio
Also in the portfolio
- Day One Biopharmaceuticals
- Scilex Holding Company
- Hummingbird Bioscience
- Alcresta
- Iovance Biotherapeutics
- Lassen Therapeutics
- Radionetics Oncology
- Avadel Pharmaceuticals
- Scout Bio
- Iterum Therapeutics
- VIVUS
- Passage Bio
- Alpine Immune Sciences
- Outpost Medicine
- Sierra Oncology
- Molecular Templates
- Chimerix
- Tricida
- Epizyme
- ESSA Pharma
- IVERIC bio
- Entasis Therapeutics
- Knipper Health
- Cerexa Inc.
- AcertaPharma
- The CORE Institute
- InnerPulse
- Calibrium
- PreCision Dermatology
- Calibra Medical
- Simpata
- Incline Therapeutics
- Zeltiq Aesthetics
- CV Therapeutics
- Avera Pharmaceutical
- Quantum Dot
- ZymoGenetics
- Xenoport
- Fast Track
- MEDCHANNEL
- Cotherix
- Corixa
- Tularik